Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk [0.03%]
成人组织细胞增生症中单核细胞亚群纵向动态变化的生物标志物意义：与突变状态、激酶抑制剂暴露及复发风险的相关性研究
Jerome Razanamahery,Caroline Raymond,Matthias Papo et al.
Jerome Razanamahery et al.
Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study [0.03%]
急性白血病中核孔蛋白98的重排：一项基因组全景研究
Osama Batayneh,Natalie Danziger,Mahmoudreza Moein et al.
Osama Batayneh et al.
Nucleoporin 98 rearrangements (NUP98re) occur in a wide range of hematologic malignancies including acute leukemias with a variety of fusion partners. NUP98re is associated with adverse prognosis, especially in children. We aimed to better ...
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy [0.03%]
替扎奇替尼、费德塔宾、帕克利汀和莫美洛汀二线治疗骨髓纤维化的匹配调整间接比较
Yi Zhang,Hu Zhou,Qike Zhang et al.
Yi Zhang et al.
Ruxolitinib is first-line therapy for intermediate/high-risk myelofibrosis (MF), but ∼50% of patients discontinue within 1 year due to loss of efficacy or intolerance. Four JAK inhibitors (gecacitinib, fedratinib, pacritinib, momelotinib) ...
Comparative Study
Hematological oncology. 2026 Sep;44(5):e70230. DOI:10.1002/hon.70230 2026
Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T-Cell Lymphoma: A Real-World National Cancer Database Study [0.03%]
自身干细胞巩固移植与血管免疫性T细胞淋巴瘤患者总生存改善相关：一项全国癌症数据库真实世界研究
Yu Tao,Huijun Li,Ayo S Falade et al.
Yu Tao et al.
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive peripheral T-cell lymphoma with poor outcomes, and the role of autologous stem cell transplantation (ASCT) as consolidation after frontline therapy remains controversial. We conduct...
Clinical Impact of BTK Inhibitor Exposure in LymphGen-Defined MCD Diffuse Large B-Cell Lymphoma [0.03%]
淋巴生成MCD型弥漫性大B细胞淋巴瘤中BTK抑制剂暴露的临床影响
Shiyu Jiang,Yizhen Liu,Ran Wei et al.
Shiyu Jiang et al.
The molecular subtype characterized by co-occurring MYD88 and CD79B alterations (MCD) represents a biologically distinct subset of diffuse large B-cell lymphoma (DLBCL) with chronic active B-cell receptor signaling and a high risk of centra...
Real-World Luspatercept Evidence in Myelodysplastic Neoplasms: A Systematic Review and Bayesian Meta-Analysis [0.03%]
Luspatercept真实世界证据在骨髓增生性肿瘤中的应用：系统回顾和贝叶斯meta分析
Pedro Robson Costa Passos,Valbert Oliveira Costa Filho,Roberto Cavalcante Venâncio et al.
Pedro Robson Costa Passos et al.
Luspatercept has emerged as a therapeutic option for patients with lower-risk myelodysplastic neoplasms (MDS). Nonetheless, the performance of luspatercept outside of controlled clinical trials remains unclear. We aimed to synthesize real-w...
Meta-Analysis
Hematological oncology. 2026 Jul;44(4):e70226. DOI:10.1002/hon.70226 2026
Cost-Effectiveness of Epcoritamab Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab for Relapsed/Refractory Follicular Lymphoma: A US Payer Perspective [0.03%]
艾普可单抗联合来那度胺和利妥昔单抗治疗复发/难治性滤泡淋巴瘤的经济效果：美国医保方视角
Yongtao He,Meiyu Wu,Andong Li et al.
Yongtao He et al.
The Phase 3 EPCORE FL-1 trial demonstrated that adding epcoritamab to lenalidomide plus rituximab (R2) significantly improved response rates and prolonged progression-free survival in patients with relapsed or refractory (r/r) follicular ly...
Comparative Study
Hematological oncology. 2026 Jul;44(4):e70221. DOI:10.1002/hon.70221 2026
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma [0.03%]
供者来源对成人T细胞白血病/淋巴瘤异基因造血干细胞移植后疗效影响的时机依赖性分析
Hidehiro Itonaga,Takuya Fukushima,Hiroyuki Muranushi et al.
Hidehiro Itonaga et al.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is usually performed as a curative treatment for adult T-cell leukemia/lymphoma (ATL), following first-line chemotherapy. We conducted a nationwide retrospective study to examin...
Clinical Significance of FLT3-ITD Variation Allele Frequency in Acute Myeloid Leukemia: A Multicenter Study [0.03%]
FLT3-ITD变异等位基因频率在急性髓系白血病中的临床意义：一项多中心研究
Laibing Guo,Jingyan Song,Haoyu Zang et al.
Laibing Guo et al.
The specific prognostic impact of FLT3-ITD variant allele frequency (VAF) in acute myeloid leukemia (AML) remains unclear. In this multi-center study of 190 AML patients harboring FLT3-ITD mutations, a VAF cut-off of 40% was applied. Patien...
Multicenter Study
Hematological oncology. 2026 Jul;44(4):e70218. DOI:10.1002/hon.70218 2026
Low-Dose Chidamide Maintenance Therapy After Hematopoietic Stem Cell Transplantation for T-Cell Acute Lymphoblastic Leukemia: A Case Series [0.03%]
低剂量化德沙利芦巴林用于T细胞急性淋巴细胞白血病异基因造血干细胞移植后的维持治疗：病例系列报告
Shen-Hao Liu,Ai-Ni Deng,Hui-Ying Li et al.
Shen-Hao Liu et al.
Post-transplant relapse remains a major challenge in T-ALL, with limited effective salvage options. We report on eight T-ALL patients who received low-dose chidamide (5 mg once weekly) as maintenance therapy after allogeneic HSCT. With a me...
Case Reports
Hematological oncology. 2026 Jul;44(4):e70225. DOI:10.1002/hon.70225 2026